Digoxin therapy and the risk of primary cardiac arrest in patients with congestive heart failure: Effect of mild-moderate renal impairment

Journal of Clinical Epidemiology

Volumn 56, Issue 7, 2003, Pages 646-650

  Rea, Thomas D ^a   Siscovick, David S ^a,b   Psaty, Bruce M ^b   Pearce, Rachel M ^a   Raghunathan, Trivellore E ^c   Whitsel, Eric A ^d   Cobb, Leonard A ^a   Weinmann, Sheila ^a   Anderson, Gail D ^b   Arbogast, Patrick ^f   Lin, Danyu ^e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e IL   (United States)

^f VANDERBILT UNIVERSITY   (United States)

Author keywords

Digoxin; Heart arrest; Heart failure; Kidney

Indexed keywords

DIGOXIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; HEART ARREST; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0041559802     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(03)00075-1     Document Type: Article

References (17)

1. Stafford R.S., Saglam D., Blumenthal D. National patterns of angiotensinconverting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 157:1997;2460-2464.
2. Cohn J.N. An explanation for varying views about digitalis efficacy in congestive heart failure. Cardiovasc Drugs Ther. 3:1989;19-20.
3. Hauptman P.J., Kelly R.A. Digitalis. Circulation. 99:1999;1265-1270.
4. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533.
5. Smith T.W. Digitalis: mechanism of action and clinical use. N Engl J Med. 318:1988;358-365.
6. Jelliffe R.W., Brooker G. A nomogram for digoxin therapy. Am J Med. 57:1974;63-68.
7. Fisch C., Knoebel S.B. Digitalis cardiotoxicity. J Am Coll Cardiol. 5:(Suppl A):1985;91A-98A.
8. Marik P.E., Fromm L. A case series of hospitalized patients with elevated digoxin levels. Am J Med. 105:1998;110-115.
9. Report of the Joint International Society and Federation Task Force of Cardiology. World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation. 59:1979;607-609.
10. Siscovick D.S. Challenges in cardiac arrest research: data collection to assess outcomes. Ann Emerg Med. 22:1993;92-98.
11. Smith H.W. Diseases of the kidney and urinary tract. The kidney: structure and function in health and disease. 1951;836-887 Oxford Univ Press, New York.
12. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41.
13. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 130:1999;461-470.
14. Knight E.L., Glynn R.J., McIntyre K.M., Mogun H., Avorn J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction. Am Heart J. 138:1999;849-855.
15. Philbin E.F., Santuella R.N., Rocco T.A. Jr. Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction. J Am Geriatr Soc. 47:1999;302-308.
16. Surawicz B. Factors affecting tolerance to digitalis. J Am Coll Cardiol. 5:1985;69A-81A.
17. Bakris G.L., Weir M.R. Angiotensin-converting enzyme inhibitor - associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 160:2000;685-693.